MYC and cancer: Although halving the basal Myc-dose in p53KO mice substantially extended tumor-free lifespan, animals inevitably succumbed to cancer (>90%) suggesting that extra Myc accelerates a pathologic trajectory programmed by the germline loss of Trp53.